Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | SRCE | PLBL |
|---|---|---|
| Price | $86.26 | $5.67 |
| Change today | ▼ 0.68% | ▲ 0.35% |
| Market cap | $2.08B | $2.08B |
| Return, 3 months | +6.1% | -43.4% |
| Return, year to date | +40.4% | -48.3% |
| Return, 1 year | +45.0% | -30.9% |
| P/E (TTM) | 12.4 | -354.4 |
| P/B | 1.6 | -45.7 |
| P/E percentile vs own 5y | 94th | 28th |
| Dividend yield | 1.87% | – |
| Revenue growth (YoY, latest qtr) | +9.2% | -12.6% |
| Net profit growth (YoY) | +27.4% | +45.6% |
| Gross margin | – | 7.3% |
| Operating margin | – | -28.6% |
| Net margin | 40.2% | -22.6% |
| Return on equity | – | – |
| Analyst target vs. price | +8.4% | – |
| Analyst buy share | 50% | – |
| RSI (14) | 52 | 49 |
| 30-day volatility | 12.6% | 74.4% |
| Max drawdown, 1 year | -8.4% | -56.5% |
| Trend read | Strong uptrend | Leaning bearish |
| Analyst consensus | Buy | – |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
